OWN - Quintessenz Verlags-GmbH CI - Copyright Quintessenz Verlags-GmbH OCI - Copyright Quintessenz Verlags-GmbH TA - J Orofac Pain JT - Journal of Oral & Facial Pain and Headache IS - 2333-0376 (Electronic) IS - 2333-0384 (Print) IP - 1 VI - 35 PST - ppublish DP - 2021 PG - 30-34 LA - en TI - Cognitive Behavioral Therapy for Patients with Trigeminal Neuralgia: A Feasibility Study FAU - Daniel, H Clare AU - Daniel H FAU - Poole, Jolyon Ji AU - Poole J FAU - Klein, Helene AU - Klein H FAU - Huang, Cleo AU - Huang C FAU - Zakrzewska, Joanna M AU - Zakrzewska J CN - OT - cognitive behavioral therapy OT - facial pain OT - fear OT - pain management OT - multidisciplinary OT - patient satisfaction OT - quality of life OT - trigeminal neuralgia AB - Aims: To test the feasibility and acceptability of a customized six-session cognitive behavioral therapy (CBT) group intervention for adults with recurrent trigeminal neuralgia (TN). Methods: Fifteen participants with TN were recruited from a specialist facial pain unit in London, United Kingdom. The effects of the group intervention were evaluated using validated self-report measures, which the participants completed before and after the intervention and at 1-month and 9-month follow-ups. A semi-structured interview was also used at the 1-year follow-up to gather qualitative feedback of the group intervention. Results: Participants reported an increase in confidence in managing everyday tasks in the presence of TN symptoms, a reduction in negative beliefs about pain, and an increase in engagement in meaningful activity. All patients completed the group intervention (100% retention rate). Qualitative feedback highlighted that the group CBT intervention was helpful, and no participants reported a worsening of mood or experience as a result of the intervention. Conclusion: The trends for improvement in several domains, plus the positive experiences of the participants, suggest that a CBT management program is acceptable and feasible for this population and should be further developed and implemented on a larger scale to determine its clinical efficacy. AID - 1088555